{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:46:37Z","timestamp":1790649997207,"version":"4.1.0"},"reference-count":63,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>\n                    Antimicrobial resistance is a global public health emergency. The World Health Organization recently highlighted the growing number of new sexually transmitted infections such as gonorrhea, syphilis, and Chlamydia, which are resistant to common antibiotics. The phenomenon is also on the rise due to increasing intercontinental travel. Emerging antibiotic-resistant strains of gonorrhea are particularly associated with international spread from Southeast Asian travelers. Infection with\n                    <jats:italic toggle=\"yes\">Neisseria gonorrhoeae<\/jats:italic>\n                    can cause a wide spectrum of associated diseases such as dermatitis, arthritis and septic arthritis, and pelvic inflammatory disease, and can even lead to serious health consequences for the individual. Natural infection confers no immunity, and vaccination is not available currently, although in several countries, it has been reported that the antimeningococcal vaccine may protect against gonorrhea. Implementing all necessary preventive measures is crucial, as well as appropriate and timely diagnostic methods and effective antimicrobial therapeutic treatments in the correct modalities to avoid the increase of forms of gonorrhea that are resistant to common antibiotics and difficult to eradicate.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2023.0259","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T15:17:25Z","timestamp":1712330245000},"page":"297-303","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Antimicrobial Resistance in Gonorrhea"],"prefix":"10.1177","volume":"30","author":[{"given":"Antonio","family":"Vitiello","sequence":"first","affiliation":[{"name":"Ministry of Health, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, Asl Napoli 3 Sud, Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Boccellino","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Ponzo","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Pavia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Sabbatucci","sequence":"additional","affiliation":[{"name":"Department Infectious Diseases, Italian National Institute of Health, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zovi","sequence":"additional","affiliation":[{"name":"Ministry of Health, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-9496-0_3","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea","volume":"1997","author":"Unemo M","year":"2019","unstructured":"Unemo M, , Golparian D, , Eyre DW. Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea. Methods Mol Biol, 2019; 1997:37\u201358; doi: 10.1007\/978-1-4939-9496-0_3","journal-title":"Methods Mol Biol"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00010-14"},{"issue":"1","key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo M","year":"2019","unstructured":"Unemo M, , Seifert HS, , Hook EW, et al. Gonorrhoea. Nat Rev Dis Primers, 2019; 5(1):79; doi: 10.1038\/s41572-019-0128-6","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/cid\/ciac052","article-title":"Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core Surveillance (ABCs)-United States, 2015\u20132019","volume":"75","author":"Weston EJ","year":"2022","unstructured":"Weston EJ, , Heidenga BL, , Farley MM, et al. Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core Surveillance (ABCs)-United States, 2015\u20132019. Clin Infect Dis, 2022; 75(6):953\u2013958; doi: 10.1093\/cid\/ciac052","journal-title":"Clin Infect Dis"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.19-0288"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-019-00651-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.08.010"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.08.008"},{"key":"e_1_3_3_10_2","unstructured":"European Centre for Disease Prevention and Control; Surveillance Atlas of Infectious Diseases. Available from: https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx. [Last accessed: August 31 2023]."},{"key":"e_1_3_3_11_2","unstructured":"World of Health Organization. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241549691. [Last accessed: January 12 2023]."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00021"},{"issue":"5","key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1071\/SH19034","article-title":"New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance","volume":"16","author":"Lewis DA","year":"2019","unstructured":"Lewis DA. New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance. Sex Health, 2019; 16(5):449\u2013456; doi: 10.1071\/SH19034","journal-title":"Sex Health"},{"key":"e_1_3_3_14_2","unstructured":"Centers for Disease Control and Prevention. Avaialble from: https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6950a6.htm. [Last accessed: January 13 2023]."},{"issue":"4","key":"e_1_3_3_15_2","first-page":"381","article-title":"Ceftriaxone","volume":"27","author":"Gupta AK","year":"1990","unstructured":"Gupta AK, , Wadhwa A, , Anand NK. Ceftriaxone. Indian Pediatr, 1990; 27(4):381\u2013384.","journal-title":"Indian Pediatr"},{"issue":"12","key":"e_1_3_3_16_2","first-page":"900","article-title":"Ceftriaxone: A third-generation cephalosporin","volume":"19","author":"Nahata MC","year":"1985","unstructured":"Nahata MC, , Barson WJ. Ceftriaxone: A third-generation cephalosporin. Drug Intell Clin Pharm, 1985; 19(12):900\u2013906; doi: 10.1177\/106002808501901203","journal-title":"Drug Intell Clin Pharm"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"112739","DOI":"10.1016\/j.ejmech.2020.112739","article-title":"Azithromycin: The first broad-spectrum therapeutic","volume":"207","author":"Firth A","year":"2020","unstructured":"Firth A, , Prathapan P. Azithromycin: The first broad-spectrum therapeutic. Eur J Med Chem, 2020; 207:112739; doi: 10.1016\/j.ejmech.2020.112739","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_18_2","article-title":"Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017\u20132018","author":"Yuan Q","year":"2019","unstructured":"Yuan Q, , Li Y, , Xiu L, et al. Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017\u20132018. Emerg Microbes Infect, 2019;8(1):1546\u20131549; doi: 10.1080\/22221751.2019.1681242","journal-title":"Emerg Microbes Infect"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1512757"},{"issue":"4","key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bjm.2017.06.001","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: History, molecular mechanisms and epidemiological aspects of an emerging global threat","volume":"48","author":"Barros Dos Santos KT","year":"2017","unstructured":"Costa-Louren\u00e7o APRD, Barros Dos Santos KT, , Moreira BM, et al. Antimicrobial resistance in Neisseria gonorrhoeae: History, molecular mechanisms and epidemiological aspects of an emerging global threat. Braz J Microbiol, 2017; 48(4):617\u2013628; doi: 10.1016\/j.bjm.2017.06.001","journal-title":"Braz J Microbiol"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-2931-x"},{"issue":"3","key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/OLQ.0000000000000556","article-title":"Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015","volume":"44","author":"Yasuda M","year":"2017","unstructured":"Yasuda M, , Hatazaki K, , Ito S, et al. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015. Sex Transm Dis, 2017; 44(3):149\u2013153; doi: 10.1097\/OLQ.0000000000000556","journal-title":"Sex Transm Dis"},{"key":"e_1_3_3_23_2","unstructured":"Centers for Disease Control and Prevention. Available from: https:\/\/www.cdc.gov\/std\/gonorrhea\/treatment.htm#:~:text=What%20is%20the%20treatment%20for treat%20urogenital%20or%20rectal%20gonorrhea [Last accessed: January 14 2023]."},{"issue":"4","key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/clinchem\/hvab026","article-title":"The next-generation of neisseria gonorrhoeae antimicrobial resistance testing","volume":"67","author":"Potter RF","year":"2021","unstructured":"Potter RF, , Ransom EM, , Burnham CD. The next-generation of neisseria gonorrhoeae antimicrobial resistance testing. Clin Chem, 2021; 67(4):573\u2013575; doi: 10.1093\/clinchem\/hvab026","journal-title":"Clin Chem"},{"issue":"10","key":"e_1_3_3_25_2","first-page":"931","article-title":"Diagnosis and management of gonococcal infections","volume":"86","author":"Mayor MT","year":"2012","unstructured":"Mayor MT, , Roett MA, , Uduhiri KA. Diagnosis and management of gonococcal infections. Am Fam Physician, 2012; 86(10):931\u2013938.","journal-title":"Am Fam Physician"},{"issue":"19","key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM199111073251903","article-title":"A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group","volume":"325","author":"Handsfield HH","year":"1991","unstructured":"Handsfield HH, , McCormack WM, , Hook EW, et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med, 1991; 325(19):1337\u20131341; doi: 10.1056\/NEJM199111073251903","journal-title":"N Engl J Med"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122182"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462419886775"},{"issue":"03","key":"e_1_3_3_29_2","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines","volume":"64","author":"Workowski KA","year":"2015","unstructured":"Workowski KA, , Bolan GA, CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep, 2015; 64(RR-03):1\u2013137.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_30_2","unstructured":"Australasian Sexual Health Alliance (ASHA). Gonorrhoea. Available from: https:\/\/www.sti.guidelines.org.au\/sexually-transmissible-infections\/gonorrhoea#management [Last accessed: August31 2023]."},{"key":"e_1_3_3_31_2","unstructured":"World Health Organization (WHO). WHO guidelines for the treatment of Neisseria gonorrhoeae. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241549691 [Last accessed: August31 2023]."},{"issue":"1","key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13756-020-00805-7","article-title":"Azithromycin resistant gonococci: A literature review","volume":"9","author":"Derbie A","year":"2020","unstructured":"Derbie A, , Mekonnen D, , Woldeamanuel Y, et al. Azithromycin resistant gonococci: A literature review. Antimicrob Resist Infect Control, 2020; 9(1):138; doi: 10.1186\/s13756-020-00805-7","journal-title":"Antimicrob Resist Infect Control"},{"key":"e_1_3_3_33_2","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in the European Union\/European Economic Area \u2013 Results summary 2020. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Eurogasp-gonococcal-antimicrobial-surveillance-EU-EEA-2020.pdf [Last accessed: August31 2023]."},{"issue":"18","key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"2100917","DOI":"10.2807\/1560-7917.ES.2022.27.18.2100917","article-title":"Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: A global, systematic review, 1 January 2012 to 27 September 2020","volume":"27","author":"Medland NA","year":"2022","unstructured":"Medland NA, , Zhang Y, , Gunaratnam P, et al. Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: A global, systematic review, 1 January 2012 to 27 September 2020. Euro Surveill, 2022; 27(18):2100917; doi: 10.2807\/1560-7917.ES.2022.27.18.2100917","journal-title":"Euro Surveill"},{"issue":"5","key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM198707303170504","article-title":"Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae","volume":"317","author":"Boslego JW","year":"1987","unstructured":"Boslego JW, , Tramont EC, , Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med, 1987; 317(5):272\u2013278; doi: 10.1056\/NEJM198707303170504","journal-title":"N Engl J Med"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2201.151247"},{"key":"e_1_3_3_37_2","unstructured":"GASP WHO. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/who-gonococcal-amr-surveillance-programme-who-gasp [Last accessed: November 4 2023]."},{"issue":"6","key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/sti.2010.044164","article-title":"European surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"86","author":"Cole MJ","year":"2010","unstructured":"Cole MJ, , Chisholm SA, , Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect, 2010; 86(6):427\u2013432; doi: 10.1136\/sti.2010.044164","journal-title":"Sex Transm Infect"},{"issue":"10","key":"e_1_3_3_39_2","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiw420","article-title":"Genomic epidemiology of Gonococcal resistance to extended-Spectrum Cephalosporins, macrolides, and Fluoroquinolones in the United States, 2000\u20132013","volume":"214","author":"Grad YH","year":"2016","unstructured":"Grad YH, , Harris SR, , Kirkcaldy RD, et al. Genomic epidemiology of Gonococcal resistance to extended-Spectrum Cephalosporins, macrolides, and Fluoroquinolones in the United States, 2000\u20132013. J Infect Dis, 2016; 214(10):1579\u20131587; doi: 10.1093\/infdis\/jiw420","journal-title":"J Infect Dis"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks036"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002344"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000280"},{"key":"e_1_3_3_43_2","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","author":"Allen VG","year":"2013","unstructured":"Allen VG, , Mitterni L, , Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA, 2013;309(2):163\u2013170; doi: 10.1001\/jama.2012.17657","journal-title":"JAMA"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101188"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.012617"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.683901"},{"issue":"7","key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/vaccines11071264","article-title":"The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria","volume":"11","author":"Khalid K","year":"2023","unstructured":"Khalid K, , Poh CL. The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria. Vaccines (Basel), 2023; 11(7):1264; doi: 10.3390\/vaccines11071264","journal-title":"Vaccines (Basel)"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810499"},{"issue":"2","key":"e_1_3_3_49_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00788-10","article-title":"Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada","volume":"55","author":"Allen VG","year":"2011","unstructured":"Allen VG, , Farrell DJ, , Rebbapragada A, et al. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother, 2011; 55(2):703\u2013712; doi: 10.1128\/AAC.00788-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"e_1_3_3_50_2","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-like structure of penicillin binding protein 2 gene [penA] in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime","volume":"46","author":"Ameyama S","year":"2002","unstructured":"Ameyama S, , Onodera S, , Takahata M, et al. Mosaic-like structure of penicillin binding protein 2 gene [penA] in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother, 2002; 46(12):3744\u20133749; doi: 10.1128\/AAC.46.12.3744-3749.2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00007435-200305000-00004","article-title":"Molecular characterization of ciprofloxacin resistance of gonococcal strainsin Spain","volume":"30","author":"Alcal\u00e1 B","year":"2003","unstructured":"Alcal\u00e1 B, , Arreaza L, , Salcedo C, et al. Molecular characterization of ciprofloxacin resistance of gonococcal strainsin Spain. Sex Transm Dis, 2003; 30(5):395\u2013398; doi: 10.1097\/00007435-200305000-00004","journal-title":"Sex Transm Dis"},{"issue":"15","key":"e_1_3_3_52_2","doi-asserted-by":"crossref","first-page":"18832","DOI":"10.2807\/ese.13.15.18832-en","article-title":"Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales","volume":"13","author":"Chisholm SA","year":"2008","unstructured":"Chisholm SA, , Ison C. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. Euro Surveill, 2008; 13(15):18832; doi: 10.2807\/ese.13.15.18832-en","journal-title":"Euro Surveill"},{"issue":"1","key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s101560170034","article-title":"Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase","volume":"7","author":"Akasaka S","year":"2001","unstructured":"Akasaka S, , Muratani T, , Yamada Y, et al. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. J Infect Chemother, 2001; 7(1):49\u201350; doi: 10.1007\/s101560170034","journal-title":"J Infect Chemother"},{"issue":"8","key":"e_1_3_3_54_2","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1473-3099(23)00359-6","article-title":"Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis","volume":"23","author":"Whiley DM","year":"2023","unstructured":"Whiley DM, , Tickner JA, , Kundu RL, et al. Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis. Lancet Infect Dis, 2023; 23(8):e268\u2013e269; doi: 10.1016\/S1473-3099(23)00359-6","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_3_55_2","article-title":"Resistance and prevalence implications of doxycycline post-exposure prophylaxis for gonorrheaprevention in men who have sex with men: A modeling study","author":"Reichert E","year":"2023","unstructured":"Reichert E, Grad YH. Resistance and prevalence implications of doxycycline post-exposure prophylaxis for gonorrheaprevention in men who have sex with men: A modeling study. medRxiv, 2023:2023.04.24.23289033; doi: 10.1101\/2023.04.24.23289033","journal-title":"medRxiv"},{"key":"e_1_3_3_56_2","doi-asserted-by":"crossref","first-page":"1248613","DOI":"10.3389\/fimmu.2023.1248613","article-title":"Immune responses to Neisseria gonorrhoeae and implications for vaccine development","volume":"14","author":"Belcher T","year":"2023","unstructured":"Belcher T, , Rollier CS, , Dold C, et al. Immune responses to Neisseria gonorrhoeae and implications for vaccine development. Front Immunol, 2023:14:1248613; doi: 10.3389\/fimmu.2023.1248613","journal-title":"Front Immunol"},{"issue":"7","key":"e_1_3_3_57_2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","article-title":"Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: A retrospective observational study","volume":"22","author":"Abara WE","year":"2022","unstructured":"Abara WE, , Bernstein KT, , Lewis FMT, et al. Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: A retrospective observational study. Lancet Infect Dis, 2022; 22(7):1021\u20131029; doi: 10.1016\/S1473-3099(21)00812-4","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"e_1_3_3_58_2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","article-title":"Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: An observational cohort and case-control study","volume":"22","author":"Wang B","year":"2022","unstructured":"Wang B, , Giles L, , Andraweera P, et al. Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: An observational cohort and case-control study. Lancet Infect Dis, 2022; 22(7):1011\u20131020; doi: 10.1016\/S1473-3099(21)00754-4","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"e_1_3_3_59_2","first-page":"277","article-title":"Countering antibiotic resistance: A new course of action is needed","volume":"114","author":"Ferrara F","year":"2023","unstructured":"Ferrara F, , Zovi A, , Nava E, et al. Countering antibiotic resistance: A new course of action is needed. Recenti Prog Med, 2023; 114(5):277\u2013283; doi: 10.1701\/4032.40076","journal-title":"Recenti Prog Med"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2023.02.003"},{"key":"e_1_3_3_61_2","unstructured":"World of Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/44863 [Last accessed: August29 2023]."},{"issue":"3","key":"e_1_3_3_62_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.idc.2011.05.003","article-title":"Globalization and infectious diseases","volume":"25","author":"Frenk J","year":"2011","unstructured":"Frenk J, , G\u00f3mez-Dant\u00e9s O, , Knauldoi FM. Globalization and infectious diseases. Infect Dis Clin North Am, 2011; 25(3):593\u2013599, viii; doi: 10.1016\/j.idc.2011.05.003","journal-title":"Infect Dis Clin North Am"},{"key":"e_1_3_3_63_2","unstructured":"UNWTO. Annual report 2016. Madrid Spain: United Nations World Tourism Organization; 2017. Available from: https:\/\/www.unwto.org\/archive\/global\/publication\/unwto-annual-report-2016 [Last accessed: January13 2023]."},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1071\/SH19061"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2023.0259","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2023.0259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2023.0259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:41:22Z","timestamp":1777668082000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2023.0259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1089\/mdr.2023.0259"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2023.0259","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}